Patent · US Active

Anti-human GPVI antibodies and uses thereof

US10842870B2 · kind B2 · utility

2Cited by
9References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 5, 2016
Grant dateNov 24, 2020
Priority date—
Expiry dateAug 5, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to humanized anti-human GPVI antibodies and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.